Prognostic factors for hyperdiploid-myeloma: Effects of chromosome 13 deletions and IgH translocations

W. J. Chng, R. Santana-Dávila, S. A. Van Wier, G. J. Ahmann, S. M. Jalal, P. L. Bergsagel, M. Chesi, M. C. Trendle, S. Jacobus, E. Blood, M. M. Oken, K. Henderson, R. A. Kyle, M. A. Gertz, M. Q. Lacy, A. Dispenzieri, P. R. Greipp, Rafael Fonseca

Research output: Contribution to journalArticle

107 Scopus citations

Abstract

Chromosomal hyperdiploidy is the defining genetic signature in 40-50% of myeloma (MM) patients. We characterize hyperdiploid-MM (H-MM) in terms of its clinical and prognostic features in a cohort of 220 H-MM patients entered into clinical trials. Hyperdiploid-myeloma is associated with male sex, kappa immunoglobulin subtype, symptomatic bone disease and better survival compared to nonhyperdiploid-MM (median overall survival 48 vs 35 months, log-rank P = 0.023), despite similar response to treatment. Among 108 H-MM cases with FISH studies for common genetic abnormalities, survival is negatively affected by the existence of immunoglobulin heavy chain (IgH) translocations, especially those involving unknown partners, while the presence of chromosome 13 deletion by FISH did not significantly affect survival (median overall survival 50 vs 47 months, log-rank P = 0.47). Hyperdiploid-myeloma is therefore a unique genetic subtype of MM associated with improved outcome with distinct clinical features. The existence of IgH translocations but not chromosome 13 deletion by FISH negatively impacts survival and may allow further risk stratification of this population of MM patients.

Original languageEnglish (US)
Pages (from-to)807-813
Number of pages7
JournalLeukemia
Volume20
Issue number5
DOIs
StatePublished - May 2006

Keywords

  • Chromosome 13 deletion
  • Hyperdiploid
  • IgH translocations
  • Myeloma
  • Prognosis

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Prognostic factors for hyperdiploid-myeloma: Effects of chromosome 13 deletions and IgH translocations'. Together they form a unique fingerprint.

  • Cite this

    Chng, W. J., Santana-Dávila, R., Van Wier, S. A., Ahmann, G. J., Jalal, S. M., Bergsagel, P. L., Chesi, M., Trendle, M. C., Jacobus, S., Blood, E., Oken, M. M., Henderson, K., Kyle, R. A., Gertz, M. A., Lacy, M. Q., Dispenzieri, A., Greipp, P. R., & Fonseca, R. (2006). Prognostic factors for hyperdiploid-myeloma: Effects of chromosome 13 deletions and IgH translocations. Leukemia, 20(5), 807-813. https://doi.org/10.1038/sj.leu.2404172